ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)

ENDRA Life Sciences has disclosed FCF Margin across 3 years of filings, most recently posting 39713.15% for Q1 2018.

• In Q1 2018, FCF Margin changed N/A year-over-year to 39713.15%; the TTM figure through Dec 2018 stood at 126376.43% (down 12543767.0% YoY), while the FY2018 annual figure was 126376.43%, down 12543543.0% from the prior year.
• FCF Margin retreated to 39713.15% in Q1 2018, from 20081.52% in the prior quarter.
• Over the last five years, FCF Margin for NDRA reached as high as 105.93% in Q4 2016 and fell as low as 39713.15% in Q1 2018.
• The 3-year median for FCF Margin is 1977.51% (2017), against an average of 12413.71%.
• The widest YoY moves for FCF Margin: up 1997559 bps in 2017, down 1997559 bps in 2017.
• A 3-year view of FCF Margin shows it stood at 105.93% in 2016, then plunged by 18857 bps to 20081.52% in 2017, then tumbled by 98 bps to 39713.15% in 2018.
• According to Business Quant data, FCF Margin over the past three periods registered 39713.15%, 20081.52%, and 190.46% for Q1 2018, Q4 2017, and Q3 2017 respectively.